Results - Announcements
Shree Ganesh Remedies Ltd share price declined by 3.34% to Rs 617.0. The Company's net profit saw a strong growth of 45.54% to Rs 1.63 crore, while revenue from operations increased sharply by 62.19% to Rs 23.29 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.66 lakh crore, easing 4.55%. It has inched up 4.66% over last one week and gained upto 1.10% in last one month while the market capitalization of Shree Ganesh Remedies Ltd has slipped by 2.13% and 0.88% in the same period respectively.
Profit before tax (PBT) of Shree Ganesh Remedies Ltd stood at Rs 2.26 crore in Q3 FY26, nosediving by 66.32% year-on-year, and jumping 47.71% quarter-on-quarter. EBITDA came in at Rs 3 crore, crashing by 71.78% YoY and gaining 4.56% sequentially.
Total expenses surged 62.53% to Rs 21.86 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 13.8 crore, surging by 64.29% YoY, while employee benefits expense was at Rs 3.13 crore, inching up 6.83% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 0.64% to Rs 109.29 crore, while net profit tanked by 23.02% to Rs 17.76 crore, compared to previous TTM. EBITDA surged by 3539% to Rs 31.99 crore, and PBT tumbled by 23.22% to Rs 24.01 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 0.0 crore in FY26, as against Rs 0.0 crore in FY25.
Shree Ganesh Remedies Ltd soared by 23.45% in last one year, significantly outperforming the benchmark BSE Sensex which has reduced by 11.78% during the same period.